Search results
Drug for rare form of Lou Gehrig’s disease OK'd by FDA
AP Finance via Yahoo Finance· 1 year agoFood and Drug Administration regulators on Tuesday approved a first-of-a-kind drug for a rare form...
Huntington's vs. ALS: What Are the Differences?
Verywell Health via Yahoo News· 1 year agoMedically reviewed by Lindsay Cook, PharmD Huntington's disease (HD) and amyotrophic lateral sclerosis (ALS) are progressive neurodegenerative...
ALS drug wins FDA approval despite questionable data
Associated Press via Yahoo News· 2 years agoA much-debated drug for Lou Gehrig’s disease won U.S. approval Thursday, a long-sought victory for patients that is likely to renew questions about the...
FDA still skeptical of ALS drug ahead of high-stakes meeting
Associated Press via Yahoo News· 2 years agoFederal health regulators remain unconvinced about the benefits of a closely watched experimental...
The FDA's Mixed Messages Sent Amylyx Pharmaceuticals Stock Off A Cliff
Investor's Business Daily· 2 years agoThe Food and Drug Administration offered mixed messages Friday for Amylyx Pharmaceuticals'...
Highly Rated Amylyx Pharma Skids After Hard-Fought FDA Approval For ALS Drug
Investor's Business Daily· 2 years agoThe Food and Drug Administration has granted Amylyx Pharmaceuticals a hard-won approval in ALS...
Amylyx, A Top 5% Biotech Stock, Just Scored A Huge Win In ALS Treatment
Investor's Business Daily· 1 year agoA new treatment from Amylyx Pharmaceuticals crushed Wall Street's fourth-quarter expectations,...
Why IPO Stock Amylyx Pharmaceuticals Is Beginning To Heat Up — Again
Investor's Business Daily· 2 years agoRecent initial public offering Amylyx Pharmaceuticals jumped Monday as the Food and Drug...
FDA staff reviewers raise concerns over BrainStorm Cell's ALS therapy (Sept 25)
Reuters via AOL· 9 months agoThe U.S. Food and Drug Administration's staff reviewers raised concerns on Monday over the safety...
ALS drug pulled from market in US, Canada after trial shows it doesn't work
Euronews via Yahoo News· 3 months agoThe pharmaceutical company behind a drug for amyotrophic lateral sclerosis (ALS) said it would start...